Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations

Journal of Medical Virology

Volumn 50, Issue 2, 1996, Pages 188-192

  Robinson, John W ^a,b   Rosas, Marcela ^a   Guzman, Fanny ^a   Patarroyo, Manuel Elkin ^a   Moreno, Alberto ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Hospital San Juan de Dios   (Colombia)

Author keywords

HCV; Latin America; Seroprevalence

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; SCREENING; SOUTH AMERICA;

AMINO ACID SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; INDIANS, SOUTH AMERICAN; MASS SCREENING; MOLECULAR SEQUENCE DATA; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 0029999975     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199610)50:2<188::AID-JMV13>3.0.CO;2-I     Document Type: Article

References (35)

1. Alter HJ (1989): Chronic consequences of non-A, non-B hepatitis. In: Seeff LB, Lewis JH, eds. "Current Perspectives in Hepatology." New York: Plenum Medical Books, pp 83-97.
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerger MA, Sampliner RE, Meeks EL, Beach MJ (1992): The natural history of community-acquired infection in the United States. The New England Journal of Medicine 327: 1899-1905.
3. Amador R, Moreno A, Murillo LA, Sierra O, Saavedra O, Rojas M, Mora AL, Rocha CL, Alvarado F, Falla JC, Orozco M, Coronell C, Ortega N, Molano A, Velásquez JF, Valero MV, Franco L, Guzmán F, Salazar LM, Espejo F, Mora E, Farfán R, Zapata N, Rosas J, Calvo JC, Castro J, Quiñones T, Nuñez F, Patarroyo ME (1992): Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial. The Journal of Infectious Diseases 166:139-144.
4. Banic DM, Viana Martins FS, De Souza JM, Peixoto TD, Daniel Ribeiro C (1991): Polyclonal B-lymphocyte stimulation in human malaria and its association with ongoing parasitemia. American Journal of Tropical Medicine and Hygiene 44:571-577.
5. Blitz-Dorfman L, Monealye F, Atencio R, Monzon M, Favorov MO, Fields HA, Pujol FH, Echevarria JM (1995): Serological survey of viral hepatitis agents among Yupka Amerindian populations from western Venezuela. Absence of hepatitis C infection. Fifth International Symposium on Hepatitis C and Related Viruses, Marriot Surfers Paradise Resort, Gold Coast, Australia, C 181.
6. Callahan JD, Constantine NT, Kataaha P, Zhang X, Hyams KC, Bansal J (1993): Second generation hepatitis C virus assays: Performance when testing African sera. Journal of Medical Virology 41:35-38.
7. Chan SW, Simmonds P, McOmish F, Yap P-L, Mitchell R, Dow B, Follet E (1991): Serological activity of blood donors infected with three types of hepatitis C virus. Lancet 338:1391.
8. Ching W-M, Wychowski C, Beach MJ, Wang H, Davies CL, Carl M, Bradley DW, Alter HJ, Feinstone SM, Shin JW-K (1992): Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proceedings of the National Academy of Sciences USA 89:3190-3194.
9. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989): Isolation of a cDna clone derived from a blood-bourne non-A, non-B viral hepatitis genome. Science 244:359-361.
10. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW (1990): Hepatitis C virus: The major causative agent of viral non-A, non-B, hepatitis. British Medical Bulletin 46:423-441.
11. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M (1991): Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences USA 88:2451-2455.
12. Claeys H, Volckaerts A, De Beenhouwer H, Vermylen C (1992): Association of hepatitis carrier state with the occurence of hepatitis C virus core antibodies. Journal of Medical Virology 36:259-264.
13. Coursaget P, Bourdil C, Kastally R (1990): Prevalence of hepatitis C virus in Africa: Anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer. Research in Virology 141:449-454.
14. Esteban J, Esteban R, Viladomiu I, Lopez-Talavera JC, Gaonzalez A, Hernandez JM (1989): Hepatitis C virus antibodies among risk groups in Spain. Lancet ii:294-297.
15. Feucht HH, Zöllner B, Polywka S, Laufs R (1995): Study on reliability of commercially available commercial antibody tests. Journal of Clinical Microbiology 33:620-624.
16. Frommel D, Tekle-Haimanot R, Berne N, Aussei L, Verdier M, Preux P-M, Dennis F (1993): A survey of antibodies to hepatitis C virus in Ethiopia. American Journal of Tropical Medicine and Hygiene 49:435-439.
17. Houghten RA (1985): General method for the rapid solid phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proceedings of the National Academy of Sciences USA 82:5131-5135.
18. Hyams KC, Phillips IA, Moran AY, Tejada A, Wignall FS, Escamilla J (1992): Seroprevalence of hepatitis C antibody in Peru. Journal of Medical Virology 37:127-131.
19. Kotwal GJ, Baroudy BM, Kuarmoto IK, McDonald FF, Schiff GM, Holland PV, Zeldis JB (1992): Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proceedings of the National Academy of Sciences USA 89:4486-4489.
20. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcel RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989): An assay for circulating antibodies to a major etiologic virus of non-A, non-B hepatitis. Science 244:362-364.
21. Maggi F, Vatteroni ML, Pistello M, Avio CM, Cecconi N, Panicucci F, Bendinelli M (1995): Serological reactivity and viral genotypes in hepatitis C infection. Journal of Clinical Microbiology 33:209-211.
22. McOmish F, Cahn SW, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap P-L, Follet EAC, Simmonds P (1993): Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serological reactivity and rate of alanine transferase abnormalities. Transfusion 33:7-13.
23. Merrifield B (1986): Solid phase peptide synthesis. Science 232:341.
24. Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, Machado IV (1992): Risk factors for dialysis associated hepatitis C in Venezuela. Kidney International 41:1055-1058.
25. Nakagiri I, Ichihara K (1995): ELISA for anti-HCV antibody employing a shorter synthetic core region peptide. Journal of Virological Methods 52:195-207.
26. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM (1991): Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proceedings of the National Academy of Sciences USA 88:5462-5466.
27. Nkengasong JN, De Beenhouwer H, Claeys H, Nyambi P, Ayuk J, Van der Groen G, Ndumbe P (1995): A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in Southern Cameroon. American Journal of Tropical Medicine and Hygiene 52:98-100.
28. Noya OG, Berti YG, Alarcón de Noya B, Borges R, Zerpa N, Urbáez JD, Madonna A, Garrido E, Jimenéz MA, Borges RE, Garcia P, Reyes I, Prieto W, Colmenares C, Pabón R, Barraez T, de Caceres LG, Godoy N, Sifontes R (1994): A population-based clinical trial with the SPfB6 synthetic Plasmodium falciparum malaria vaccine in Venezuela. The Journal of Infectious Diseases 170:396-402.
29. Roggendorf M, Deinardt F, Rasahoffer R, Eberle J, Hopf U, Moller B, Zachoval R, Pape G, Schramm W, Rommel F (1989): Antibodies to hepatitis C virus. Lancet 11:324-325.
30. SällbergM, Rüden U, Wahren B, Magnius LO (1992): Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: The isotypes and the recognition. Immunology Letters 33:27-34.
31. Schreeberger P, van der Nat H, van Dijk W, and van Loon A (1994): Diagnosis of hepatitis C virus infection using two second generation enzyme immunoassays with a recombinant immunoblot for confirmation. European Journal of Clinical Microbiology and Infectious Disease 13:118-121.
32. Sempértegui F, Estrella B, Mocoso J, Piedrahita LC, Hernández D, Gaybor J, Naranjo P, Mancero O, Arias S, Bernai R, Córdova ME, Suárez J, Zicker F (1993): Safety, immunogenicity and protective effect of the Spf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador. Vaccine 12:337-342.
33. Tibbs CJ Palmer SJ, Coker R, Clark SK, Parsons GM, Hojvat S, Peterson D, Bantavala JE (1991): Prevalence of hepatitis C in tropical communities: The importance of confirmatory assays. Journal of Medical Virology 34:143-147.
34. Watson JP, Brind AM, Chapman CE, Bates CL, Gould FK, Johnson SJ, Burt AD, Ferguson J, Simmonds P, Bassendine MF (1996): Hepatitis C virus: Epidemiology and genotypes in the north east of England. Gut (in press).
35. Zein NN, Rakela J, Persing DH (1995): Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clinic Proceedings 70:449-452.